Myovant Sciences EPS - Earnings per Share 2017-2022 | MYOV

Myovant Sciences eps - earnings per share from 2017 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Myovant Sciences Annual EPS
2022 $-2.22
2021 $-2.83
2020 $-3.37
2019 $-4.09
2018 $-2.41
2017 $-1.70
2016 $-0.04
Myovant Sciences Quarterly EPS
2022-03-31 $-0.64
2021-12-31 $-0.68
2021-09-30 $-0.23
2021-06-30 $-0.67
2021-03-31 $-0.89
2020-12-31 $-0.82
2020-09-30 $-0.75
2020-06-30 $-0.37
2020-03-31 $-0.73
2019-12-31 $-0.96
2019-09-30 $-0.79
2019-06-30 $-0.89
2019-03-31 $-1.08
2018-12-31 $-1.04
2018-09-30 $-0.99
2018-06-30 $-0.98
2018-03-31 $-0.82
2017-12-31 $-0.70
2017-09-30 $-0.50
2017-06-30 $-0.39
2017-03-31 $-0.26
2016-12-31 $-0.15
2016-09-30 $-0.82
2016-06-30 $-0.47
2016-03-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.879B $0.231B
Myovant Sciences Ltd. is a biopharmaceutical company. It focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders, including advanced prostate cancer. The company's product candidate consists of relugolix which are in clinical trial, an oral once-daily small molecule that acts as a gonadotropin-releasing hormone receptor antagonist. Myovant Sciences Ltd. is based in Hamilton, Bermuda.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $161.383B 9.82
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.475B 16.53
Biohaven Pharmaceutical Holding (BHVN) United States $9.944B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.681B 0.00
Emergent Biosolutions (EBS) United States $1.444B 6.18
Arcus Biosciences (RCUS) United States $1.389B 35.22
ADC Therapeutics SA (ADCT) Switzerland $0.509B 0.00
Gelesis Holdings (GLS) United States $0.362B 0.00
Zymeworks (ZYME) Canada $0.321B 0.00
Ambrx Biopharma (AMAM) United States $0.159B 0.00
Enzo Biochem (ENZ) United States $0.114B 23.50
SQZ Biotechnologies (SQZ) United States $0.093B 0.00